The contribution of rapid intraoperative cytology to the improvement of ovarian cancer staging

Gynecologic Oncology

Volumn 86, Issue 3, 2002, Pages 244-249

  Anastasiadis, P G ^a   Romanidis, K N ^a   Polichronidis, A ^a   Koutlaki, N G ^a   Tamiolakis, D ^a   Simopoulos, K ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Imprint cytology; Lymph node biopsy; Ovarian cancer staging; Peritoneal washing cytology

Indexed keywords

EOSIN; HEMATOXYLIN;

ARTICLE; CANCER CELL; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMPRINT CYTOLOGY; INTRAOPERATIVE PERIOD; LYMPH NODE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PERITONEAL WASHING CYTOLOGY; PERITONEUM; PRIORITY JOURNAL; RETROPERITONEUM;

EID: 0036446961     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6626     Document Type: Article

References (25)

1. Schueler JA, Crnelisse CJ, Hermans J, Trimbos JB, van der Burg MEL, Fleuren GJ. Prognostic factors in well-differentiated early-stage epithelial ovarian cancer. Cancer 1993;71:787-95.
2. Young RC, Walton LA, Elenberg SS, Homesley HD, Wilbanks GD, Decker DG. Adjuvant therapy in stage I and stage II epithelial ovarian cancer. N Engl J Med 1990;322:1021-7.
3. Jadhon ME, Morgan MA, Kelsten ML, Carlson JA, Mikuta JJ. Cytologic smears of peritoneal surfaces as a sampling technique in epithelial ovarian carcinoma. Obstet Gynecol 1990;75:102-5.
4. Sharifi S, Ducatman B, Wang H, Fraser J. Peritoneal washing cytology is unnecessary in gynecologic surgery for benign diseases. Cancer (Cancer Cytopathol) 1999;87:259-62.
5. Mulvany N. Cytohistologic correlation in malignant peritoneal washings: Analysis of 75 malignant fluids. Acta Cytol 1996;40:1231-9.
6. Rubin S, Wong G, Curtin J, Baharat R, Hakes T, Hoskins W. Platinum based chemotherapy of high risk stage I epithelial ovarian cancer following comprehensive surgical staging. Obstet Gynecol 1993;82:143-7.
7. Gershenson DM. Epithelial ovarian cancer. In: Copeland LJ, editors. Textbook of Gynecology. Philadelphia: Saunders, 1993;1046-82.
8. Chen SS, Lee L. Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary. Gynecol Oncol 1983;16:95-100.
9. Le Buedec G, Fondrinier E, Kauffmann P, Mansoor A, Dauplat J. Pelvic and para-aortic lymphadenectomy in primary cancer of the ovary. Presse Med 1992;21:745-9.
10. Anastasiadis P, Koutlaki N, Liberis V, Skaphida V, Tsikouras P, Galazios G. Cytologic diagnosis of axillary lymph node metastasis in breast cancer. Acta Cytol 2000;44:18-22.
11. Shabaik A, Cox C, Clark R, Reintgen D, Humphrey E, Nicosia S. Imprint cytology of needle localized breast lesions. Acta Cytol 1993;37:10-5.
12. Veneti S, Ioannidou-Mouzaka L, Toufexi H, Xenitides J, Anastasiadis P. Imprint cytology: A rapid reliable method of diagnosing breast malignancy. Acta Cytol 1996;40:649-52.
13. Quill DS, Leahy AL, Lawler RG, Finney RD. Lymph node imprint cytology for the rapid assessment of axillary node metastases in breast cancer. Br J Surg 1984;71:454-5.
14. Rubio IT, Korourian S, Cowan C, Krag DN, Colvert M, Klimberg VS. Use of touch preps for intra-operative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 1998;5:689-94.
15. Nath ME, Pinro KR, Trucco GS, Sumkin JH, Vogel VG, Bonaventura M. Utilization of touch imprint and frozen section in evaluation of sentinel node biopsy in the patient with breast cancer. Mod Pathol 1999;12:28A.
16. Suen K, Wood W, Syed A, Quenville N, Clement P. Role of imprint cytology in intra-operative diagnosis: Value and limitations. J Clin Pathol 1978;3:328-37.
17. Young RC, Decker DG, Warton JT, Piver MS, Sindelar WF, Edwards BK, Smith JP. Staging laparotomy in early ovarian cancer. JAMA 1983;250:3072-6.
18. McGowan L, Parent Lesher L, Norris HJ, Barnett M. Misstaging of ovarian cancer. Obstet Gynecol 1985;65:568-72.
19. Buchsbaum HJ, Brady MF, Delgado G, Miller A, Hoskins WJ, Manetta A, Sutton G. Surgical staging of carcinoma of the ovaries. Surg Gynecol Obstet 1989;169:226-32.
20. Tobias JS, Griffiths CT. Management of ovarian carcinoma. N Engl J Med 1976;294:818-23.
21. Cheng L, Wolf N, Rose P, Rodriguez M, Abdul-Karim F. Peritoneal washing cytology of ovarian tumors of low malignant potential: Correlation with surface ovarian involvement and peritoneal implants. Acta Cytol 1998;42:1091-4.
22. Rubin S, Dulaney E, Maurie Markman BA, Hoskins W, Saigo P, Lewis J. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma. Obstet Gynecol 1988;71:851-3.
23. Luesley DM, Williams DR, Ward K, Redman CR, Lawton FG. Prospective comparative cytologic study of direct peritoneal smears and lavage fluids in patients with epithelial ovarian cancer and benign gynecologic disease. Acta Cytol 1990;34:539-44.
24. Mottolese M, Salzano M, Vincenzoni C, Benevolo M, Bigotti A, Iacovelli A, et al. The use of a panel of monoclonal antibodies can lower false negative diagnoses of peritoneal washings in ovarian tumors. Cancer 1991;68:1803-7.
25. Petru E, Lahausen M, Tamussino K, Pickel H, Stranzl H, Stettner H, Winter R. Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol 1994;170:656-62.